ArticleOncotarget2017

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer.

Xinyan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.